Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)

被引：19

作者：

Lip, Gregory Y. H. ^{[1
]}

Skjoth, Flemming ^{[1
]}

Rasmussen, Lars Hvilsted ^{[1
]}

Nielsen, Peter B. ^{[1
]}

Larsen, Torben Bjerregaard ^{[1
]}

机构：

[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 04期

关键词：

STROKE RISK;

D O I：

10.1016/j.jacc.2015.05.044

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：488 / 490

页数：4

共 5 条

[1] Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable [J].

Connolly, Stuart J. ;

Eikelboom, John W. ;

Ng, Jennifer ;

Hirsh, Jack ;

Yusuf, Salim ;

Pogue, Janice ;

de Caterina, Raffaele ;

Hohnloser, Stefan ;

Hart, Robert G. .

ANNALS OF INTERNAL MEDICINE, 2011, 155 (09) :579-U41

[2] Benefit of Anticoagulation Unlikely in Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1 [J].

Friberg, Leif ;

Skeppholm, Mika ;

Terent, Andreas .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (03) :225-232

[3] Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score [J].

Lip, Gregory Y. H. ;

Skjoth, Flemming ;

Rasmussen, Lars Hvilsted ;

Larsen, Torben Bjerregaard .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (14) :1385-1394

[4] The risks of risk scores for stroke risk assessment in atrial fibrillation [J].

Nielsen, Peter Bronnum ;

Chao, Tze-Fan .

THROMBOSIS AND HAEMOSTASIS, 2015, 113 (06) :1170-1173

[5] Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher? [J].

Olesen, Jonas Bjerring ;

Torp-Pedersen, Christian .

THROMBOSIS AND HAEMOSTASIS, 2015, 113 (06) :1165-1169

← 1 →